Lifetime management of patients with severe aortic stenosis

Sponsored by Boston Scientific

Anchorperson: D. Blackman

Moderator: R. Campante Teles

Summary

Don't miss this PCR London Valves 2021 session if you wish to discuss the importance of lifetime management in patients with severe aortic stenosis, to learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry, and to understand how valve design, implant technique, embolic protection, coronary access, and future redo procedures affect valve choice.

Learning Objectives

To learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry
To discuss the importance of lifetime management in patients with severe aortic stenosis
To understand how valve design, implant technique, embolic protection, coronary access, and future redo procedures affect valve choice